Results 221 to 230 of about 1,822,518 (269)

Follow-Up Report of a Case of Solid-Pseudopapillary Pancreatic Neoplasm with Four Resections in 30 Years

Daiki Horiba, Hiroyuki Sugimoto, Naoki Mashita, Masayuki Tsutsuyama, Daisuke Kobayashi, Yoshinari Mochizuki, Kenji Taniguchi   +6 more
openalex   +2 more sources

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Dual Tumor Pathogenesis in the Gastrointestinal Tract: Synchronous Rectal Schwannoma and Gallbladder Papillary Adenocarcinoma-A Case Report. [PDF]

Reports (MDPI)
Cotovanu A, Cosma CD, Molnar C, Gurzu S, Beleaua MA, Butiurca VO, Botoncea M.   +6 more
europepmc   +1 more source

Prevalence of neoplasms in acromegaly: a Turkish single-center retrospective study

Gülsüm Yüzbaşıoğlu Mirza, Mümtaz Takır, Cündullah Torun, Özgür Bahadır   +3 more
openalex   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Care for patients with hematologic neoplasms: contextual analysis resulting from a scoping review. [PDF]

Rev Bras Enferm
Azevedo IC, Silva LACD, Augusto EA, Azevedo VD, Santos VEP, Oliveira ACS.   +5 more
europepmc   +1 more source

Glimpse into Routine EMG Findings of Patients with Malign Neoplasms

Handan Uzunçakmak Uyanık
openalex   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. [PDF]

Oncol Res
Chuang CH, Tsai PK, Kao SW, Wang YH, Yeh CB.   +4 more
europepmc   +1 more source